Bentley Pharmaceutical - Best Pharma Stocks of 2007

Company: Bentley Pharmaceutical
Starting stock price: $10.18
Ending stock price: $15.09
Percent Change: 48.23%

Details: Bentley Pharmaceutical has taken a two-pronged approach to the drug business. Its emerging drug delivery business focuses on commercializing products in the U.S., and its generics unit targets the European Union. It’s the seventh largest generics company in spain with a growing portfolio of drugs for cardio, gastrointestinal, infectious disease, and central nervous system uses. In October, the company announced that it would split these two businesses and consider “strategic alternatives” for the generics portion.

In the U.S., Bentley is working on a delivery technology that allows drugs to permeate membranes; it can be used in patches, gels, ointments, creams and emulsions. The company also has been developing an intranasal insulin product. It filed an SEC registration statement near year’s end to spin off this portion of the business into an independent company.

Bentley Pharmaceutical - Best Pharma Stocks of 2007

Suggested Articles

Teva is reportedly going for a moonshot with a $15 billion drug offer to settle its opioid cases. It's a plan that might just work, one analyst said.

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Influential U.S. cost watchdog ICER gave its blessing to Johnson & Johnson and Amarin's CV drugs. But there's a big catch for both meds.